Zydus Cadila - Search Videos

Zydus Cadila Q4 | Ebitda Above Estimates

Zydus Cadila Q4 | Ebitda Above Estimates

timesnownews.comPankaj Poddar

CEO of Indian Pharmaceutical giant Zydus Cadila, Pankaj Patel informed that industry has produced 20 crore Hydroxychloroquine tablets which are in high demand worldwide amid COVID-19 outbreak. “Pharmaceutical industry has significantly increased the production of hydroxychloroquine (HCQ). 20 crore tablets of HCQ have been produced by the industry this month,” said Pankaj Patel, CEO of Zydus Cadila, in Ahmedabad. | The Times of India

CEO of Indian Pharmaceutical giant Zydus Cadila, Pankaj Patel informed that industry has produced 20 crore Hydroxychloroquine tablets which are in high demand worldwide amid COVID-19 outbreak. “Pharmaceutical industry has significantly increased the production of hydroxychloroquine (HCQ). 20 crore tablets of HCQ have been produced by the industry this month,” said Pankaj Patel, CEO of Zydus Cadila, in Ahmedabad. | The Times of India

17.7K viewsApr 11, 2020

FacebookThe Times of India

Zydus Cadila likely to get emergency use approval for its COVID vaccine this week: Sources

Zydus Cadila likely to get emergency use approval for its COVID vaccine this week: Sources

Zydus Cadila seeks emergency use authorisation for its DNA COVID-19 vaccine from DCGI

Zydus Cadila seeks emergency use authorisation for its DNA COVID-19 vaccine from DCGI

Zydus Cadila MD Dr Shervil Patel speaks to NDTV about a brand new COVID-19 vaccine which is in phase 3 trials. "The vaccine is the first DNA vaccine in the country and is part of the country's largest clinical trials," says Dr Patel adding that the "vaccine will work on kids above 12 as well". | NDTV

18.7K viewsMay 7, 2021

Zydus Cadila's Zykov-D Vaccine Effective On 12-Year-Olds, Company Seeks Approval For Emergency Use

Zydus Cadila's Zykov-D Vaccine Effective On 12-Year-Olds, Company Seeks Approval For Emergency Use

Zydus Cadila vaccine may get nod this week, will be first jab for 12-18 year olds

Zydus Cadila vaccine may get nod this week, will be first jab for 12-18 year olds

India TodayMilan Sharma

Zydus Cadila Covid vaccine gets DCGI nod for human clinical trials

India TodayPress Trust of India

Zydus To Produce 1 Crore Doses Per Month By October, Says Chief

Zydus Cadila gets FDA's approval to market generic cancer drug in US

Zydus Cadila plans to complete late-stage trials for its candidate for the novel coronavirus vaccine by February or March. It could produce up to 100 million doses a year initially if it is successful, according to the company chairman on Friday. Cadila’s vaccine candidate, known as ZyCov-D, is one of dozens being developed around the world to fight the coronavirus pandemic. | The Times of India

23.8K viewsJul 18, 2020

FacebookThe Times of India

Zydus Cadila seeks Emergency Use Authorisation for its Covid-19 vaccine ZyCoV-D in India

COVID-19 vaccine: Zydus Cadila seeks emergency use approval of 'ZyCoV-D' for 12 years and above | https://bit.ly/3waDQhJ | The Economic Times

4K viewsJul 1, 2021

FacebookThe Economic Times

Vaaccine Update: Zydus Cadila ZyCoV-D is Okayed for Children

timesnownews.com

Zydus Cadila seeks nod for human trial of Covid-19 antibody cocktail

India TodayIndia Today Television

Zydus Cadila seeks Emergency Use Authorisation to launch ZyCoV-D and has applied to DGCA. Zydus claims its vaccine is 66.6 per cent effective against symptomatic Covid-19 cases and 100 per cent for moderate disease. Cadila vaccine is found to be safe for children aged 12-18 years. #COVID19 #ZyCovD #zyduscadila | All News

122 viewsJul 1, 2021

FacebookAll News

Zydus Cadila gets approval for emergency use; authorization from the drug controller general of India

timesnownews.com

Zydus Cadila To Seek Emergency Nod For Vaccine?

NDTVGargi Rawat

Zydus Cadila Shot For 12-18 Soon, Centre Informs Supreme Court |

Zydus Cadila gets tentative nod from US health regulator to market type-2 diabetes drug

ZyCoV-D: Zydus Cadila’s Needle-Free COVID Vaccine’s Official Pricing Announced

Govt panel recommends emergency use authorisation to Zydus Cadila's 3-dose Covid vaccine

Zydus Cadila's Virafin gets DGCI approval for treating moderate Covid infection in adults

Zydus Cadila's ZyCov-D: All About World’s First DNA Vaccine For Covid | 10 Points

Zydus Cadila proposes price for 3-dose Covid vaccine ZyCov-D. Details

Zydus Cadila begins enrolment for Phase 3 vaccine trial: Reports

Zydus Cadila COVID-19 vaccine to be available soon for 12-18 age group: Centre

Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources

Zydus Cadila targets the end of the year for a vaccine launch: Chairman

Zydus Cadila seeks emergency use approval for COVID vaccine for 12 years old and above

See more